Feedback / Questions
Bismab-A (lintuzumab-Bi-213) - Actinium
Actinium: Future Leaders in the Biotech Industry
(Actinium Pharmaceuticals)
-
Mar 27, 2015 -
Discontinuation of development due to supply, logistics, and cost reasons
Discontinued
•
Oncology
http://www.actiniumpharma.com/wp-content/uploads/ATNM-Presentation-March.pdf
Mar 27, 2015
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
.